Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and ...

Omada Health, a 14-year-old digital health company supporting chronic disease patients, has yet to generate profits.

RFK Jr.'s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this ...

The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.

President Trump's 2026 budget proposes cutting NIH grants to universities, academic medical centers, and other institutions ...

A large government study published Thursday shows more definitively than ever before that Americans’ self-reported race is a ...

It looks like the NIH is thinking about AI differently than the FDA, who earlier this week released a “rushed” AI tool across ...

HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

An Otsuka drug succeeded in a Phase 3 study in a chronic kidney disease, with results that outperformed a competitor's recent ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

From STAT’s Adam Feuerstein: Another example of why biotech is a tough business.